<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32230811</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>27</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2316</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21072316</ELocationID><Abstract><AbstractText>Neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), increase as the population ages around the world. Environmental factors also play an important role in most cases. Alcohol consumption exists extensively and it acts as one of the environmental factors that promotes these neurodegenerative diseases. The brain is a major target for the actions of alcohol, and heavy alcohol consumption has long been associated with brain damage. Chronic alcohol intake leads to elevated glutamate-induced excitotoxicity, oxidative stress and permanent neuronal damage associated with malnutrition. The relationship and contributing mechanisms of alcohol with these three diseases are different. Epidemiological studies have reported a reduction in the prevalence of Alzheimer's disease in individuals who drink low amounts of alcohol; low or moderate concentrations of ethanol protect against &#x3b2;-amyloid (A&#x3b2;) toxicity in hippocampal neurons; and excessive amounts of ethanol increase accumulation of A&#x3b2; and Tau phosphorylation. Alcohol has been suggested to be either protective of, or not associated with, PD. However, experimental animal studies indicate that chronic heavy alcohol consumption may have dopamine neurotoxic effects through the induction of Cytochrome P450 2E1 (<i>CYP2E1</i>) and an increase in the amount of &#x3b1;-Synuclein (&#x3b1;SYN) relevant to PD. The findings on the association between alcohol consumption and ALS are inconsistent; a recent population-based study suggests that alcohol drinking seems to not influence the risk of developing ALS. Additional research is needed to clarify the potential etiological involvement of alcohol intake in causing or resulting in major neurodegenerative diseases, which will eventually lead to potential therapeutics against these alcoholic neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Departments of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Hubei Provincial Key Lab for Quality and Safety of Traditional Chinese Medicine Health Food, Jing Brand Research Institute, Daye 435100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B Joshi</LastName><ForeName>Rachna</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departments of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine, Stafford Medical, PA. 1364 NJ-72, Manahawkin, NJ 08050, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuancai</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hubei Provincial Key Lab for Quality and Safety of Traditional Chinese Medicine Health Food, Jing Brand Research Institute, Daye 435100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbar</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neuroscience &amp; Behavior, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD 20852, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Byoung-Joon</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0002-3954-3497</Identifier><AffiliationInfo><Affiliation>Section of Molecular Pharmacology and Toxicology, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shuanhu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Departments of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical><Chemical><RegistryNumber>3K9958V90M</RegistryNumber><NameOfSubstance UI="D000431">Ethanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000428" MajorTopicYN="N">Alcohol Drinking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000431" MajorTopicYN="N">Ethanol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">alcohol</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32230811</ArticleId><ArticleId IdType="pmc">PMC7177420</ArticleId><ArticleId IdType="doi">10.3390/ijms21072316</ArticleId><ArticleId IdType="pii">ijms21072316</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hou Y.J., Dan X.L., Babbar M., Wei Y., Hasselbalch S.G., Croteau D.L., Bohr V.A. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 2019;15:565&#x2013;581. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss-Coray T. Ageing, neurodegeneration and brain rejuvenation. Nature. 2016;539:180&#x2013;186. doi: 10.1038/nature20411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20411</ArticleId><ArticleId IdType="pmc">PMC5172605</ArticleId><ArticleId IdType="pubmed">27830812</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniele S., Giacomelli C., Martini C. Brain ageing and neurodegenerative disease: The role of cellular waste management. Biochem. Pharmacol. 2018;158:207&#x2013;216. doi: 10.1016/j.bcp.2018.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2018.10.030</ArticleId><ArticleId IdType="pubmed">30393045</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick K.L., Bell S.L., Weindel C.G., Watson R.O. Exploring the &#x201c;Multiple-Hit Hypothesis&#x201d; of Neurodegenerative Disease: Bacterial Infection Comes up to Bat. Front. Cell. Infect. Microbiol. 2019;9 doi: 10.3389/fcimb.2019.00138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00138</ArticleId><ArticleId IdType="pmc">PMC6546885</ArticleId><ArticleId IdType="pubmed">31192157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersi M., Irvine B., Gupta P., Gomes J., Birkett N., Krewski D. Risk factors associated with the onset and progression of Alzheimer&#x2019;s disease: A systematic review of the evidence. Neurotoxicology. 2017;61:143&#x2013;187. doi: 10.1016/j.neuro.2017.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2017.03.006</ArticleId><ArticleId IdType="pubmed">28363508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball N., Teo W.P., Chandra S., Chapman J. Parkinson&#x2019;s Disease and the Environment. Front. Neurol. 2019;10 doi: 10.3389/fneur.2019.00218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00218</ArticleId><ArticleId IdType="pmc">PMC6433887</ArticleId><ArticleId IdType="pubmed">30941085</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time. Nat. Rev. Neurol. 2013;9:617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerri C., Pascual M. Mechanisms involved in the neurotoxic, cognitive, and neurobehavioral effects of alcohol consumption during adolescence. Alcohol. 2010;44:15&#x2013;26. doi: 10.1016/j.alcohol.2009.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alcohol.2009.10.003</ArticleId><ArticleId IdType="pubmed">20113871</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C., Yang Q., Liu Y., Zhou S., Jiang J., Reiter R.J., Bhattacharya P., Cui Y., Yang H., Ma H., et al. The multiple protective roles and molecular mechanisms of melatonin and its precursor N-acetylserotonin in targeting brain injury and liver damage and in maintaining bone health. Free Radic. Biol. Med. 2019;130:215&#x2013;233. doi: 10.1016/j.freeradbiomed.2018.10.402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.10.402</ArticleId><ArticleId IdType="pubmed">30315933</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohno K., Niihara H., Hamano T., Takeda M., Nakagawa Y., Shiwaku K., Nabika T., Zoller B., Li X.J., Sundquist K., et al. J-curve association between alcohol intake and varicose veins in Japan: The Shimane CoHRE Study. J. Dermatol. 2019;46:902&#x2013;906. doi: 10.1111/1346-8138.15022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.15022</ArticleId><ArticleId IdType="pubmed">31353631</ArticleId></ArticleIdList></Reference><Reference><Citation>Planas-Ballve A., Grau-Lopez L., Morillas R.M., Planas R. Neurological manifestations of excessive alcohol consumption. Gastroenterol. Hepatol. 2017;40:709&#x2013;717. doi: 10.1016/j.gastre.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gastre.2017.11.001</ArticleId><ArticleId IdType="pubmed">28651796</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson R.F., Hermon C., Liu B., Green J., Reeves G.K., Beral V., Flou S., Abbott S., Alison R., Armstrong M., et al. Alcohol drinking patterns and liver cirrhosis risk: Analysis of the prospective UK Million Women Study. Lancet Public Health. 2019;4:E41&#x2013;E48. doi: 10.1016/S2468-2667(18)30230-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(18)30230-5</ArticleId><ArticleId IdType="pmc">PMC6323353</ArticleId><ArticleId IdType="pubmed">30472032</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrani A., Boubekri N., Lassad S., Zama D., Benayache F., Benayache S. Alcohol Induced Hepato Cardiotoxicity and Oxidative Damage in Rats: The Protective Effect of n-butanol Extract of Green Tea (Camellia sinensis (L.) Kuntze) Cardiovasc. Hematol. Disord. Drug Targets. 2017;17:18&#x2013;23. doi: 10.2174/1871529X17666170310101727.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871529X17666170310101727</ArticleId><ArticleId IdType="pubmed">28294073</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillemacher T., Bachmann O., Kahl K.G., Frieling H. Alcohol, microbiome, and their effect on psychiatric disorders. Prog. Neuro Psychopharmacol. 2018;85:105&#x2013;115. doi: 10.1016/j.pnpbp.2018.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2018.04.015</ArticleId><ArticleId IdType="pubmed">29705711</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H.Y., Fisher P., Harris D., Tseng T.S. Alcohol intake patterns for cancer and non-cancer individuals: A population study. Transl. Cancer Res. 2019;8:S334&#x2013;S335. doi: 10.21037/tcr.2019.06.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tcr.2019.06.31</ArticleId><ArticleId IdType="pmc">PMC6731030</ArticleId><ArticleId IdType="pubmed">31497514</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachdaoui N., Sarkar D.K. Pathophysiology of the Effects of Alcohol Abuse on the Endocrine System. Alcohol Res. 2017;38:255&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5513689</ArticleId><ArticleId IdType="pubmed">28988577</ArticleId></ArticleIdList></Reference><Reference><Citation>Boule L.A., Kovacs E.J. Alcohol, aging, and innate immunity. J. Leukoc. Biol. 2017;102:41&#x2013;55. doi: 10.1189/jlb.4RU1016-450R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.4RU1016-450R</ArticleId><ArticleId IdType="pmc">PMC6608055</ArticleId><ArticleId IdType="pubmed">28522597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A., Schwarzschild M.A. The epidemiology of Parkinson&#x2019;s disease: Risk factors and prevention. Lancet Neurol. 2016;15:1257&#x2013;1272. doi: 10.1016/S1474-4422(16)30230-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30230-7</ArticleId><ArticleId IdType="pubmed">27751556</ArticleId></ArticleIdList></Reference><Reference><Citation>Kioumourtzoglou M.A., Rotem R.S., Seals R.M., Gredal O., Hansen J., Weisskopf M.G. Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study. JAMA Neurol. 2015;72:905&#x2013;911. doi: 10.1001/jamaneurol.2015.0910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.0910</ArticleId><ArticleId IdType="pmc">PMC4975611</ArticleId><ArticleId IdType="pubmed">26030836</ArticleId></ArticleIdList></Reference><Reference><Citation>Gushcha V.K., Lelevich S.V., Sheibak V.M. Neurotransmitter disturbances in some parts of the rat brain and their correction under chronic and intermittent alcohol intoxication. Biomeditsinskaya Khimiya. 2019;65:21&#x2013;27. doi: 10.18097/PBMC20196501021.</Citation><ArticleIdList><ArticleId IdType="doi">10.18097/PBMC20196501021</ArticleId><ArticleId IdType="pubmed">30816093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuntsche E., Kuntsche S., Thrul J., Gmel G. Binge drinking: Health impact, prevalence, correlates and interventions. Psychol. Health. 2017;32:976&#x2013;1017. doi: 10.1080/08870446.2017.1325889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08870446.2017.1325889</ArticleId><ArticleId IdType="pubmed">28513195</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q., Luo C., Zhang X., Liu Y., Wang Z., Cacciamani P., Shi J., Cui Y., Wang C., Sinha B., et al. Tartary buckwheat extract alleviates alcohol-induced acute and chronic liver injuries through the inhibition of oxidative stress and mitochondrial cell death pathway. Am. J. Transl. Res. 2020;12:70&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7013218</ArticleId><ArticleId IdType="pubmed">32051738</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammoud N., Jimenez-Shahed J. Chronic Neurologic Effects of Alcohol. Clin. Liver Dis. 2019;23:141&#x2013;155. doi: 10.1016/j.cld.2018.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cld.2018.09.010</ArticleId><ArticleId IdType="pubmed">30454828</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies M.J., Baer D.J., Judd J.T., Brown E.D., Campbell W.S., Taylor P.R. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: A randomized controlled trial. JAMA. 2002;287:2559&#x2013;2562. doi: 10.1001/jama.287.19.2559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.287.19.2559</ArticleId><ArticleId IdType="pubmed">12020337</ArticleId></ArticleIdList></Reference><Reference><Citation>Booyse F.M., Pan W.S., Grenett H.E., Parks D.A., Darley-Usmar V.M., Bradley K.M., Tabengwa E.M. Mechanism by which alcohol and wine polyphenols affect coronary heart disease risk. Ann. Epidemiol. 2007;17:S24&#x2013;S31. doi: 10.1016/j.annepidem.2007.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2007.01.006</ArticleId><ArticleId IdType="pubmed">17478321</ArticleId></ArticleIdList></Reference><Reference><Citation>Toda M., Totoki T., Nakamura C., Yasuma T., Alessandro-Gabazza C.N.D., Mifuji-Moroka R., Nishihama K., Iwasa M., Horiki N., Gabazza E.C., et al. Low dose of alcohol attenuates pro-atherosclerotic activity of thrombin. Atherosclerosis. 2017;265:215&#x2013;224. doi: 10.1016/j.atherosclerosis.2017.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2017.09.005</ArticleId><ArticleId IdType="pubmed">28923781</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud S., Delorgeril M. Wine, Alcohol, Platelets, and the French Paradox for Coronary Heart-Disease. Lancet. 1992;339:1523&#x2013;1526. doi: 10.1016/0140-6736(92)91277-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(92)91277-F</ArticleId><ArticleId IdType="pubmed">1351198</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierksma A., van der Gaag M.S., Kluft C., Hendriks H.F.J. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur. J. Clin. Nutr. 2002;56:1130&#x2013;1136. doi: 10.1038/sj.ejcn.1601459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ejcn.1601459</ArticleId><ArticleId IdType="pubmed">12428180</ArticleId></ArticleIdList></Reference><Reference><Citation>Quigley E.M.M. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Curr. Neurol. Neurosci. 2017;17:94. doi: 10.1007/s11910-017-0802-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-017-0802-6</ArticleId><ArticleId IdType="pubmed">29039142</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz G., Urrutia J.C., Burgos C.F., Silva V., Aguilar F., Sama M., Yeh H.H., Opazo C., Aguayo L.G. Low concentrations of ethanol protect against synaptotoxicity induced by Abeta in hippocampal neurons. Neurobiol. Aging. 2015;36:845&#x2013;856. doi: 10.1016/j.neurobiolaging.2014.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.017</ArticleId><ArticleId IdType="pubmed">25433458</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M.A., Neafsey E.J., Wang K., Achille N.J., Mitchell R.M., Sivaswamy S. Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: Possible signaling mechanisms. Mol. Neurobiol. 2010;41:420&#x2013;425. doi: 10.1007/s12035-010-8138-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-010-8138-0</ArticleId><ArticleId IdType="pmc">PMC2908405</ArticleId><ArticleId IdType="pubmed">20422315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormeno D., Romero F., Lopez-Fenner J., Avila A., Martinez-Torres A., Parodi J. Ethanol reduces amyloid aggregation in vitro and prevents toxicity in cell lines. Arch. Med. Res. 2013;44:1&#x2013;7. doi: 10.1016/j.arcmed.2012.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2012.12.004</ArticleId><ArticleId IdType="pubmed">23291379</ArticleId></ArticleIdList></Reference><Reference><Citation>Belmadani A., Kumar S., Schipma M., Collins M.A., Neafsey E.J. Inhibition of amyloid-beta-induced neurotoxicity and apoptosis by moderate ethanol preconditioning. Neuroreport. 2004;15:2093&#x2013;2096. doi: 10.1097/00001756-200409150-00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200409150-00019</ArticleId><ArticleId IdType="pubmed">15486488</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D., Yu M., Yang S., Lou D., Zhou W., Zheng L., Wang Z., Cai F., Zhou W., Li T., et al. Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes. Mol. Neurobiol. 2018;55:5006&#x2013;5018. doi: 10.1007/s12035-017-0703-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0703-3</ArticleId><ArticleId IdType="pubmed">28799137</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman J.L., Faccidomo S., Kim M., Taylor S.M., Agoglia A.E., May A.M., Smith E.N., Wong L.C., Hodge C.W. Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer&#x2019;s disease. Int. Rev. Neurobiol. 2019;148:169&#x2013;230. doi: 10.1016/bs.irn.2019.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2019.10.017</ArticleId><ArticleId IdType="pmc">PMC6939615</ArticleId><ArticleId IdType="pubmed">31733664</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Jiang H., Xie J. Alcohol intake and risk of Parkinson&#x2019;s disease: A meta-analysis of observational studies. Mov. Disord. 2014;29:819&#x2013;822. doi: 10.1002/mds.25863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25863</ArticleId><ArticleId IdType="pubmed">24590499</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson A.K., Lofving S., Callaghan R.C., Allebeck P. Alcohol use disorders and risk of Parkinson&#x2019;s disease: Findings from a Swedish national cohort study 1972&#x2013;2008. BMC Neurol. 2013;13:190. doi: 10.1186/1471-2377-13-190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-190</ArticleId><ArticleId IdType="pmc">PMC4029307</ArticleId><ArticleId IdType="pubmed">24314068</ArticleId></ArticleIdList></Reference><Reference><Citation>Trantham-Davidson H., Chandler L.J. Alcohol-induced alterations in dopamine modulation of prefrontal activity. Alcohol. 2015;49:773&#x2013;779. doi: 10.1016/j.alcohol.2015.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alcohol.2015.09.001</ArticleId><ArticleId IdType="pmc">PMC4691370</ArticleId><ArticleId IdType="pubmed">26558348</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotermund C., Reolon G.K., Leixner S., Boden C., Bilbao A., Kahle P.J. Enhanced motivation to alcohol in transgenic mice expressing human alpha-synuclein. J. Neurochem. 2017;143:294&#x2013;305. doi: 10.1111/jnc.14151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14151</ArticleId><ArticleId IdType="pubmed">28833174</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ovidio F., Rooney J.P.K., Visser A.E., Manera U., Beghi E., Logroscino G., Vermeulen R.C.H., Veldink J.H., van den Berg L.H., Hardiman O., et al. Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study. J. Neurol. Neurosurg. Psychiatry. 2019;90:11&#x2013;19. doi: 10.1136/jnnp-2018-318559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318559</ArticleId><ArticleId IdType="pubmed">30076269</ArticleId></ArticleIdList></Reference><Reference><Citation>Amodio R., Esposito E., De Ruvo C., Bellavia V., Amodio E., Carruba G. Red wine extract prevents neuronal apoptosis in vitro and reduces mortality of transgenic mice. Ann. N. Y. Acad. Sci. 2006;1089:88&#x2013;97. doi: 10.1196/annals.1386.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1386.026</ArticleId><ArticleId IdType="pubmed">17261757</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelkonen A., Hiltunen M., Kiianmaa K., Yavich L. Stimulated dopamine overflow and alpha-synuclein expression in the nucleus accumbens core distinguish rats bred for differential ethanol preference. J. Neurochem. 2010;114:1168&#x2013;1176. doi: 10.1111/j.1471-4159.2010.06844.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06844.x</ArticleId><ArticleId IdType="pubmed">20533994</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines. WHO; Geneva, Switzerland: 2019.</Citation></Reference><Reference><Citation>Eggink E., van Charante E.P.M., van Gool W.A., Richard E. A Population Perspective on Prevention of Dementia. J. Clin. Med. 2019;8:834. doi: 10.3390/jcm8060834.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8060834</ArticleId><ArticleId IdType="pmc">PMC6617301</ArticleId><ArticleId IdType="pubmed">31212802</ArticleId></ArticleIdList></Reference><Reference><Citation>Anstey K.J., Ee N., Eramudugolla R., Jagger C., Peters R. A Systematic Review of Meta-Analyses that Evaluate Risk Factors for Dementia to Evaluate the Quantity, Quality, and Global Representativeness of Evidence. J. Alzheimer&#x2019;s Dis. 2019;70:S165&#x2013;S186. doi: 10.3233/JAD-190181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190181</ArticleId><ArticleId IdType="pmc">PMC6700718</ArticleId><ArticleId IdType="pubmed">31306123</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Tan L., Wang H.F., Jiang T., Tan M.S., Tan L., Zhao Q.F., Li J.Q., Wang J., Yu J.T. Meta-analysis of modifiable risk factors for Alzheimer&#x2019;s disease. J. Neurol. Neurosurg. Psychiatry. 2015;86:1299&#x2013;1306. doi: 10.1136/jnnp-2015-310548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310548</ArticleId><ArticleId IdType="pubmed">26294005</ArticleId></ArticleIdList></Reference><Reference><Citation>Anstey K.J., Mack H.A., Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: Meta-analysis of prospective studies. Am. J. Geriatr. Psychiatry. 2009;17:542&#x2013;555. doi: 10.1097/JGP.0b013e3181a2fd07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JGP.0b013e3181a2fd07</ArticleId><ArticleId IdType="pubmed">19546653</ArticleId></ArticleIdList></Reference><Reference><Citation>Anttila T., Helkala E.L., Viitanen M., Kareholt I., Fratiglioni L., Winblad B., Soininen H., Tuomilehto J., Nissinen A., Kivipelto M. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: A prospective population based study. BMJ. 2004;329:539. doi: 10.1136/bmj.38181.418958.BE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38181.418958.BE</ArticleId><ArticleId IdType="pmc">PMC516103</ArticleId><ArticleId IdType="pubmed">15304383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabia S., Fayosse A., Dumurgier J., Dugravot A., Akbaraly T., Britton A., Kivimaki M., Singh-Manoux A. Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study. BMJ. 2018;362:k2927. doi: 10.1136/bmj.k2927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k2927</ArticleId><ArticleId IdType="pmc">PMC6066998</ArticleId><ArticleId IdType="pubmed">30068508</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller S., Montandon M.L., Rodriguez C., Herrmann F.R., Giannakopoulos P. Impact of Coffee, Wine, and Chocolate Consumption on Cognitive Outcome and MRI Parameters in Old Age. Nutrients. 2018;10:1391. doi: 10.3390/nu10101391.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10101391</ArticleId><ArticleId IdType="pmc">PMC6212945</ArticleId><ArticleId IdType="pubmed">30275380</ArticleId></ArticleIdList></Reference><Reference><Citation>Stampfer M.J., Kang J.H., Chen J., Cherry R., Grodstein F. Effects of moderate alcohol consumption on cognitive function in women. N. Engl. J. Med. 2005;352:245&#x2013;253. doi: 10.1056/NEJMoa041152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa041152</ArticleId><ArticleId IdType="pubmed">15659724</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo E., Dufouil C., Marcos G., Quetglas B., Saz P., Guallar E., Lobo A., Workgroup Z. Is there an association between low-to-moderate alcohol consumption and risk of cognitive decline? Am. J. Epidemiol. 2010;172:708&#x2013;716. doi: 10.1093/aje/kwq187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq187</ArticleId><ArticleId IdType="pubmed">20699263</ArticleId></ArticleIdList></Reference><Reference><Citation>Toda A., Tagata Y., Nakada T., Komatsu M., Shibata N., Arai H. Changes in Mini-Mental State Examination score in Alzheimer&#x2019;s disease patients after stopping habitual drinking. Psychogeriatrics. 2013;13:94&#x2013;98. doi: 10.1111/psyg.12008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/psyg.12008</ArticleId><ArticleId IdType="pubmed">23909966</ArticleId></ArticleIdList></Reference><Reference><Citation>Langballe E.M., Ask H., Holmen J., Stordal E., Saltvedt I., Selbaek G., Fikseaunet A., Bergh S., Nafstad P., Tambs K. Alcohol consumption and risk of dementia up to 27 years later in a large, population-based sample: The HUNT study, Norway. Eur. J. Epidemiol. 2015;30:1049&#x2013;1056. doi: 10.1007/s10654-015-0029-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-015-0029-2</ArticleId><ArticleId IdType="pmc">PMC4584101</ArticleId><ArticleId IdType="pubmed">25968174</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyerer S., Schaufele M., Wiese B., Maier W., Tebarth F., van den Bussche H., Pentzek M., Bickel H., Luppa M., Riedel-Heller S.G., et al. Current alcohol consumption and its relationship to incident dementia: Results from a 3-year follow-up study among primary care attenders aged 75 years and older. Age Ageing. 2011;40:456&#x2013;463. doi: 10.1093/ageing/afr007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afr007</ArticleId><ArticleId IdType="pubmed">21367764</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Deng J., Zhang M., Zhou H.D., Wang Y.J. Association between bone mineral density and the risk of Alzheimer&#x2019;s disease. J. Alzheimer&#x2019;s Dis. 2011;24:101&#x2013;108. doi: 10.3233/JAD-2010-101467.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-101467</ArticleId><ArticleId IdType="pubmed">21187587</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchsinger J.A., Tang M.X., Siddiqui M., Shea S., Mayeux R. Alcohol intake and risk of dementia. J. Am. Geriatr. Soc. 2004;52:540&#x2013;546. doi: 10.1111/j.1532-5415.2004.52159.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2004.52159.x</ArticleId><ArticleId IdType="pubmed">15066068</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamal K.J., Kuller L.H., Fitzpatrick A.L., Longstreth W.T., Jr., Mittleman M.A., Siscovick D.S. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA. 2003;289:1405&#x2013;1413. doi: 10.1001/jama.289.11.1405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.11.1405</ArticleId><ArticleId IdType="pubmed">12636463</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsay J., Laurin D., Verreault R., Hebert R., Helliwell B., Hill G.B., McDowell I. Risk factors for Alzheimer&#x2019;s disease: A prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol. 2002;156:445&#x2013;453. doi: 10.1093/aje/kwf074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwf074</ArticleId><ArticleId IdType="pubmed">12196314</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruitenberg A., van Swieten J.C., Witteman J.C., Mehta K.M., van Duijn C.M., Hofman A., Breteler M.M. Alcohol consumption and risk of dementia: The RotterdAm. Study. Lancet. 2002;359:281&#x2013;286. doi: 10.1016/S0140-6736(02)07493-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)07493-7</ArticleId><ArticleId IdType="pubmed">11830193</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W., Qiu C., Winblad B., Fratiglioni L. Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. J. Clin. Epidemiol. 2002;55:959&#x2013;964. doi: 10.1016/S0895-4356(02)00462-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(02)00462-6</ArticleId><ArticleId IdType="pubmed">12464371</ArticleId></ArticleIdList></Reference><Reference><Citation>Bate C., Williams A. Ethanol protects cultured neurons against amyloid-beta and alpha-synuclein-induced synapse damage. Neuropharmacology. 2011;61:1406&#x2013;1412. doi: 10.1016/j.neuropharm.2011.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2011.08.030</ArticleId><ArticleId IdType="pubmed">21903110</ArticleId></ArticleIdList></Reference><Reference><Citation>Marras C., Canning C.G., Goldman S.M. Environment, lifestyle, and Parkinson&#x2019;s disease: Implications for prevention in the next decade. Mov. Disord. 2019;34:801&#x2013;811. doi: 10.1002/mds.27720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27720</ArticleId><ArticleId IdType="pubmed">31091353</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas M.M., Xu Z., Tan L.C.S. Epidemiology of Parkinson&#x2019;s Disease-East versus West. Mov. Disord. Clin. Pract. 2018;5:14&#x2013;28. doi: 10.1002/mdc3.12568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.12568</ArticleId><ArticleId IdType="pmc">PMC6174379</ArticleId><ArticleId IdType="pubmed">30363342</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia L.V., Lang A.E. Parkinson&#x2019;s disease. Lancet. 2015;386:896&#x2013;912. doi: 10.1016/S0140-6736(14)61393-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61393-3</ArticleId><ArticleId IdType="pubmed">25904081</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayan S., Liew Z., Bronstein J.M., Ritz B. Occupational pesticide use and Parkinson&#x2019;s disease in the Parkinson Environment Gene (PEG) study. Environ. Int. 2017;107:266&#x2013;273. doi: 10.1016/j.envint.2017.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2017.04.010</ArticleId><ArticleId IdType="pmc">PMC5629094</ArticleId><ArticleId IdType="pubmed">28779877</ArticleId></ArticleIdList></Reference><Reference><Citation>Eric Nyam T.T., Ho C.H., Wang Y.L., Lim S.W., Wang J.J., Chio C.C., Kuo J.R., Wang C.C. The Risk of Traumatic Brain Injury Occurring among Patients with Parkinson Disease: A 14-Year Population-Based Study. World Neurosurg. 2018;113:e328&#x2013;e335. doi: 10.1016/j.wneu.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2018.02.027</ArticleId><ArticleId IdType="pubmed">29452320</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalvin L.A., Damento G.M., Yawn B.P., Abbott B.A., Hodge D.O., Pulido J.S. Parkinson Disease and Melanoma: Confirming and Reexamining an Association. Mayo Clin. Proc. 2017;92:1070&#x2013;1079. doi: 10.1016/j.mayocp.2017.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2017.03.014</ArticleId><ArticleId IdType="pmc">PMC5682925</ArticleId><ArticleId IdType="pubmed">28688464</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes K.C., Gao X., Kim I.Y., Wang M., Weisskopf M.G., Schwarzschild M.A., Ascherio A. Intake of dairy foods and risk of Parkinson disease. Neurology. 2017;89:46&#x2013;52. doi: 10.1212/WNL.0000000000004057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004057</ArticleId><ArticleId IdType="pmc">PMC5496517</ArticleId><ArticleId IdType="pubmed">28596209</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers K.M., Smith-Weller T., Franklin G.M., Longstreth W.T., Jr., Swanson P.D., Checkoway H. Dietary fats, cholesterol and iron as risk factors for Parkinson&#x2019;s disease. Parkinsonism Relat. Disord. 2009;15:47&#x2013;52. doi: 10.1016/j.parkreldis.2008.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2008.03.002</ArticleId><ArticleId IdType="pmc">PMC2751763</ArticleId><ArticleId IdType="pubmed">18424169</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Kolk N.M., de Vries N.M., Kessels R.P.C., Joosten H., Zwinderman A.H., Post B., Bloem B.R. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson&#x2019;s disease: A double-blind, randomised controlled trial. Lancet Neurol. 2019;18:998&#x2013;1008. doi: 10.1016/S1474-4422(19)30285-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30285-6</ArticleId><ArticleId IdType="pubmed">31521532</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P.C., Ahmed I., Loriot M.A., Mulot C., Paul K.C., Bronstein J.M., Ritz B., Elbaz A. Smoking and Parkinson disease: Evidence for gene-by-smoking interactions. Neurology. 2018;90:e583&#x2013;e592. doi: 10.1212/WNL.0000000000004953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004953</ArticleId><ArticleId IdType="pmc">PMC5818012</ArticleId><ArticleId IdType="pubmed">29352099</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu G., Bidel S., Jousilahti P., Antikainen R., Tuomilehto J. Coffee and tea consumption and the risk of Parkinson&#x2019;s disease. Mov. Disord. 2007;22:2242&#x2013;2248. doi: 10.1002/mds.21706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.21706</ArticleId><ArticleId IdType="pubmed">17712848</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirinzi T., Martella G., Imbriani P., Di Lazzaro G., Franco D., Colona V.L., Alwardat M., Sinibaldi Salimei P., Mercuri N.B., Pierantozzi M., et al. Dietary Vitamin E as a Protective Factor for Parkinson&#x2019;s Disease: Clinical and Experimental Evidence. Front. Neurol. 2019;10:148. doi: 10.3389/fneur.2019.00148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00148</ArticleId><ArticleId IdType="pmc">PMC6399121</ArticleId><ArticleId IdType="pubmed">30863359</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon K.C., Eberly S., Gao X., Oakes D., Tanner C.M., Shoulson I., Fahn S., Schwarzschild M.A., Ascherio A., Parkinson Study G. Mendelian randomization of serum urate and parkinson disease progression. Ann. Neurol. 2014;76:862&#x2013;868. doi: 10.1002/ana.24281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24281</ArticleId><ArticleId IdType="pmc">PMC4245314</ArticleId><ArticleId IdType="pubmed">25257975</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees K., Stowe R., Patel S., Ives N., Breen K., Clarke C.E., Ben-Shlomo Y. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson&#x2019;s disease: Evidence from observational studies. Cochrane Database Syst. Rev. 2011 doi: 10.1002/14651858.CD008454.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008454.pub2</ArticleId><ArticleId IdType="pubmed">22071848</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganini-Hill A. Risk factors for parkinson&#x2019;s disease: The leisure world cohort study. Neuroepidemiology. 2001;20:118&#x2013;124. doi: 10.1159/000054770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000054770</ArticleId><ArticleId IdType="pubmed">11359079</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios N., Gao X., O&#x2019;Reilly E., Schwarzschild M., McCullough M.L., Mayo T., Gapstur S.M., Ascherio A.A. Alcohol and risk of Parkinson&#x2019;s disease in a large, prospective cohort of men and women. Mov. Disord. 2012;27:980&#x2013;987. doi: 10.1002/mds.25050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25050</ArticleId><ArticleId IdType="pmc">PMC3548327</ArticleId><ArticleId IdType="pubmed">22714720</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul K.C., Chuang Y.H., Shih I.F., Keener A., Bordelon Y., Bronstein J.M., Ritz B. The association between lifestyle factors and Parkinson&#x2019;s disease progression and mortality. Mov. Disord. 2019;34:58&#x2013;66. doi: 10.1002/mds.27577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27577</ArticleId><ArticleId IdType="pmc">PMC6544143</ArticleId><ArticleId IdType="pubmed">30653734</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Guo X., Park Y., Wang J., Huang X., Hollenbeck A., Blair A., Chen H. Alcohol Consumption, Types of Alcohol, and Parkinson&#x2019;s Disease. PLoS ONE. 2013;8:e66452. doi: 10.1371/journal.pone.0066452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0066452</ArticleId><ArticleId IdType="pmc">PMC3686735</ArticleId><ArticleId IdType="pubmed">23840473</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukushima W., Miyake Y., Tanaka K., Sasaki S., Kiyohara C., Tsuboi Y., Yamada T., Oeda T., Miki T., Kawamura N., et al. Alcohol drinking and risk of Parkinson&#x2019;s disease: A case-control study in Japan. BMC Neurol. 2010;10:111. doi: 10.1186/1471-2377-10-111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-10-111</ArticleId><ArticleId IdType="pmc">PMC2991300</ArticleId><ArticleId IdType="pubmed">21054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoletti A., Pugliese P., Nicoletti G., Arabia G., Annesi G., Mari M.D., Lamberti P., Grasso L., Marconi R., Epifanio A., et al. Voluptuary habits and clinical subtypes of Parkinson&#x2019;s disease: The FRAGAMP case-control study. Mov. Disord. 2010;25:2387&#x2013;2394. doi: 10.1002/mds.23297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.23297</ArticleId><ArticleId IdType="pubmed">20669181</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 1999;56:33&#x2013;39. doi: 10.1001/archneur.56.1.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.56.1.33</ArticleId><ArticleId IdType="pubmed">9923759</ArticleId></ArticleIdList></Reference><Reference><Citation>Brighina L., Schneider N.K., Lesnick T.G., de Andrade M., Cunningham J.M., Mrazek D., Rocca W.A., Maraganore D.M. Alpha-synuclein, alcohol use disorders, and Parkinson disease: A case-control study. Parkinsonism Relat. Disord. 2009;15:430&#x2013;434. doi: 10.1016/j.parkreldis.2008.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2008.11.011</ArticleId><ArticleId IdType="pmc">PMC3057130</ArticleId><ArticleId IdType="pubmed">19196539</ArticleId></ArticleIdList></Reference><Reference><Citation>Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976&#x2013;1990. Neurology. 1999;52:1214&#x2013;1220. doi: 10.1212/WNL.52.6.1214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.52.6.1214</ArticleId><ArticleId IdType="pubmed">10214746</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L.C., Koh W.P., Yuan J.M., Wang R., Au W.L., Tan J.H., Tan E.K., Yu M.C. Differential effects of black versus green tea on risk of Parkinson&#x2019;s disease in the Singapore Chinese Health Study. Am. J. Epidemiol. 2008;167:553&#x2013;560. doi: 10.1093/aje/kwm338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwm338</ArticleId><ArticleId IdType="pmc">PMC2737529</ArticleId><ArticleId IdType="pubmed">18156141</ArticleId></ArticleIdList></Reference><Reference><Citation>Dick F.D., De Palma G., Ahmadi A., Scott N.W., Prescott G.J., Bennett J., Semple S., Dick S., Counsell C., Mozzoni P., et al. Environmental risk factors for Parkinson&#x2019;s disease and parkinsonism: The Geoparkinson study. Occup. Environ. Med. 2007;64:666&#x2013;672. doi: 10.1136/oem.2006.027003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oem.2006.027003</ArticleId><ArticleId IdType="pmc">PMC2078401</ArticleId><ArticleId IdType="pubmed">17332139</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson&#x2019;s disease: A clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry. 1992;55:181&#x2013;184. doi: 10.1136/jnnp.55.3.181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.55.3.181</ArticleId><ArticleId IdType="pmc">PMC1014720</ArticleId><ArticleId IdType="pubmed">1564476</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirdefeldt K., Gatz M., Pawitan Y., Pedersen N.L. Risk and protective factors for Parkinson&#x2019;s disease: A study in Swedish twins. Ann. Neurol. 2005;57:27&#x2013;33. doi: 10.1002/ana.20307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20307</ArticleId><ArticleId IdType="pubmed">15521056</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernan M.A., Logroscino G., Rodriguez L.A. A prospective study of alcoholism and the risk of Parkinson&#x2019;s disease. J. Neurol. 2004;251(Suppl. 7):vii14&#x2013;vii17. doi: 10.1007/s00415-004-1705-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-004-1705-4</ArticleId><ArticleId IdType="pubmed">15505749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernan M.A., Chen H., Schwarzschild M.A., Ascherio A. Alcohol consumption and the incidence of Parkinson&#x2019;s disease. Ann. Neurol. 2003;54:170&#x2013;175. doi: 10.1002/ana.10611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10611</ArticleId><ArticleId IdType="pubmed">12891669</ArticleId></ArticleIdList></Reference><Reference><Citation>Checkoway H., Powers K., Smith-Weller T., Franklin G.M., Longstreth W.T., Jr., Swanson P.D. Parkinson&#x2019;s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am. J. Epidemiol. 2002;155:732&#x2013;738. doi: 10.1093/aje/155.8.732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/155.8.732</ArticleId><ArticleId IdType="pubmed">11943691</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhuang W., Fu W., Wang X., Lv E., Li F., Zhou S., Rausch W.D., Wang X. The lentiviral-mediated Nurr1 genetic engineering mesenchymal stem cells protect dopaminergic neurons in a rat model of Parkinson&#x2019;s disease. Am. J. Transl. Res. 2018;10:1583&#x2013;1599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6038066</ArticleId><ArticleId IdType="pubmed">30018702</ArticleId></ArticleIdList></Reference><Reference><Citation>Landau A.M., Kouassi E., Siegrist-Johnstone R., Desbarats J. Proteasome inhibitor model of Parkinson&#x2019;s disease in mice is confounded by neurotoxicity of the ethanol vehicle. Mov. Disord. 2007;22:403&#x2013;407. doi: 10.1002/mds.21306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.21306</ArticleId><ArticleId IdType="pubmed">17230468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang Y., Ma C., Yan Y., Yang Y., Wang X., Rausch W.D. Ginsenoside Rd and ginsenoside Re offer neuroprotection in a novel model of Parkinson&#x2019;s disease. Am. J. Neurodegener. Dis. 2016;5:52&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4788731</ArticleId><ArticleId IdType="pubmed">27073742</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D., Fu W., Zhuang W., Lv C., Li F., Wang X. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson&#x2019;s disease. J. Neurosci. Res. 2017;95:907&#x2013;917. doi: 10.1002/jnr.23879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23879</ArticleId><ArticleId IdType="pubmed">27617772</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu W., Zhuang W., Zhou S., Wang X. Plant-derived neuroprotective agents in Parkinson&#x2019;s disease. Am. J. Transl. Res. 2015;7:1189&#x2013;1202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4548312</ArticleId><ArticleId IdType="pubmed">26328004</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu W., Zheng Z., Zhuang W., Chen D., Wang X., Sun X., Wang X. Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy. Int. J. Neurosci. 2013;123:883&#x2013;891. doi: 10.3109/00207454.2013.814132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2013.814132</ArticleId><ArticleId IdType="pubmed">23768098</ArticleId></ArticleIdList></Reference><Reference><Citation>Drew P.D., Johnson J.W., Douglas J.C., Phelan K.D., Kane C.J. Pioglitazone blocks ethanol induction of microglial activation and immune responses in the hippocampus, cerebellum, and cerebral cortex in a mouse model of fetal alcohol spectrum disorders. Alcohol. Clin. Exp. Res. 2015;39:445&#x2013;454. doi: 10.1111/acer.12639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.12639</ArticleId><ArticleId IdType="pmc">PMC4348240</ArticleId><ArticleId IdType="pubmed">25703036</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G.C., Wang H.C. Acute parkinsonism in alcohol withdrawal: A case report. Parkinsonism Relat. Disord. 2015;21:1385&#x2013;1386. doi: 10.1016/j.parkreldis.2015.09.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2015.09.046</ArticleId><ArticleId IdType="pubmed">26433545</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkhanis A.N., Rose J.H., Huggins K.N., Konstantopoulos J.K., Jones S.R. Chronic intermittent ethanol exposure reduces presynaptic dopamine neurotransmission in the mouse nucleus accumbens. Drug Alcohol Depend. 2015;150:24&#x2013;30. doi: 10.1016/j.drugalcdep.2015.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2015.01.019</ArticleId><ArticleId IdType="pmc">PMC4387104</ArticleId><ArticleId IdType="pubmed">25765483</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit C., Dong H., Chen Y., Thompson D.C., Deitrich R.A., Vasiliou V.K. The role of CYP2E1 in alcohol metabolism and sensitivity in the central nervous system. Subcell. Biochem. 2013;67:235&#x2013;247. doi: 10.1007/978-94-007-5881-0_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-94-007-5881-0_8</ArticleId><ArticleId IdType="pmc">PMC4314297</ArticleId><ArticleId IdType="pubmed">23400924</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaglini F., Viaggi C., Piro V., Pardini C., Gerace C., Scarselli M., Corsini G.U. Acetaldehyde and parkinsonism: Role of CYP450 2E1. Front. Behav. Neurosci. 2013;7:71. doi: 10.3389/fnbeh.2013.00071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2013.00071</ArticleId><ArticleId IdType="pmc">PMC3689266</ArticleId><ArticleId IdType="pubmed">23801948</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaut O., Schmitt I., Wullner U. Genome-scale methylation analysis of Parkinson&#x2019;s disease patients&#x2019; brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics. 2012;13:87&#x2013;91. doi: 10.1007/s10048-011-0308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-011-0308-3</ArticleId><ArticleId IdType="pubmed">22238121</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C.J., Aslam K., Drendel H.M., Asiago J.M., Goode K.M., Paul L.N., Rochet J.C., Hazbun T.R. Hsp31 Is a Stress Response Chaperone That Intervenes in the Protein Misfolding Process. J. Biol. Chem. 2015;290:24816&#x2013;24834. doi: 10.1074/jbc.M115.678367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.678367</ArticleId><ArticleId IdType="pmc">PMC4598993</ArticleId><ArticleId IdType="pubmed">26306045</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts B.J., Shoaf S.E., Jeong K.S., Song B.J. Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: Evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less. Biochem. Biophys. Res. Commun. 1994;205:1064&#x2013;1071. doi: 10.1006/bbrc.1994.2774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1994.2774</ArticleId><ArticleId IdType="pubmed">7802633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao C., Liu W., Luan X., Li Y., Gui H., Peng Y., Shen J., Hu G., Yang J. Aquaporin-4 knockout enhances astrocyte toxicity induced by 1-methyl-4-phenylpyridinium ion and lipopolysaccharide via increasing the expression of cytochrome P4502E1. Toxicol. Lett. 2010;198:225&#x2013;231. doi: 10.1016/j.toxlet.2010.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2010.06.023</ArticleId><ArticleId IdType="pmc">PMC2936815</ArticleId><ArticleId IdType="pubmed">20615459</ArticleId></ArticleIdList></Reference><Reference><Citation>Janakiraman U., Manivasagam T., Justin Thenmozhi A., Dhanalakshmi C., Essa M.M., Song B.J., Guillemin G.J. Chronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson&#x2019;s disease. Physiol. Behav. 2017;173:132&#x2013;143. doi: 10.1016/j.physbeh.2017.01.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2017.01.046</ArticleId><ArticleId IdType="pubmed">28185878</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar M., Essa M.M., Daradkeh G., Abdelmegeed M.A., Choi Y., Mahmood L., Song B.J. Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress. Brain Res. 2016;1637:34&#x2013;55. doi: 10.1016/j.brainres.2016.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.02.016</ArticleId><ArticleId IdType="pmc">PMC4821765</ArticleId><ArticleId IdType="pubmed">26883165</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., Cherng C.F., Chen C. Melatonin in concentrated ethanol and ethanol alone attenuate methamphetamine-induced dopamine depletions in C57BL/6J. mice. J. Neural Transm. 2002;109:1477&#x2013;1490. doi: 10.1007/s007020200096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007020200096</ArticleId><ArticleId IdType="pubmed">12486488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali S.F., Bondy S.C. Red wine but not ethanol at low doses can protect against the toxicity of methamphetamine. Brain Res. 2010;1346:247&#x2013;250. doi: 10.1016/j.brainres.2010.05.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.05.058</ArticleId><ArticleId IdType="pubmed">20510887</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya R.S., Mao L.L., Zhou E.W., Bowser R., Zhu Z., Zhu Y., Wang X. Neuroprotection for amyotrophic lateral sclerosis: Role of stem cells, growth factors, and gene therapy. Cent. Nerv. Syst. Agents Med. Chem. 2012;12:15&#x2013;27. doi: 10.2174/187152412800229152.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152412800229152</ArticleId><ArticleId IdType="pmc">PMC4170803</ArticleId><ArticleId IdType="pubmed">22283698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya R.S., Zhu H., Li W., Bowser R., Friedlander R.M., Wang X. Therapeutic neuroprotective agents for amyotrophic lateral sclerosis. Cell. Mol. Life Sci. 2013;70:4729&#x2013;4745. doi: 10.1007/s00018-013-1415-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1415-0</ArticleId><ArticleId IdType="pmc">PMC4172456</ArticleId><ArticleId IdType="pubmed">23864030</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Fotinos A., Mao L.L., Atassi N., Zhou E.W., Ahmad S., Guan Y., Berry J.D., Cudkowicz M.E., Wang X. Neuroprotective agents target molecular mechanisms of disease in ALS. Drug Discov. Today. 2015;20:65&#x2013;75. doi: 10.1016/j.drudis.2014.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2014.08.016</ArticleId><ArticleId IdType="pubmed">25205348</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Liu T., Liu L., Yao X., Chen L., Fan D., Zhan S., Wang S. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. 2019 doi: 10.1007/s00415-019-09652-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09652-y</ArticleId><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowicka N., Juranek J., Juranek J.K., Wojtkiewicz J. Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2019;20:2616. doi: 10.3390/ijms20112616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112616</ArticleId><ArticleId IdType="pmc">PMC6600314</ArticleId><ArticleId IdType="pubmed">31141951</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico E., Factor-Litvak P., Santella R.M., Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2013;65:509&#x2013;527. doi: 10.1016/j.freeradbiomed.2013.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pmc">PMC3859834</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E., Fang F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr. Opin. Neurol. 2019;32:771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Elamin M., Byrne S., Hardiman O. Sexual dimorphism in ALS: Exploring gender-specific neuroimaging signatures. Amyotroph. Lateral Scler. Front. Degener. 2014;15:235&#x2013;243. doi: 10.3109/21678421.2013.865749.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.865749</ArticleId><ArticleId IdType="pubmed">24344910</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S., Visser A.E., D&#x2019;Ovidio F., Vlaanderen J., Portengen L., Beghi E., Chio A., Logroscino G., Hardiman O., Pupillo E., et al. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR. J. Neurol. Neurosurg. Psychiatry. 2019 doi: 10.1136/jnnp-2019-320986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320986</ArticleId><ArticleId IdType="pubmed">31434759</ArticleId></ArticleIdList></Reference><Reference><Citation>Seals R.M., Hansen J., Gredal O., Weisskopf M.G. Physical Trauma and Amyotrophic Lateral Sclerosis: A Population-Based Study Using Danish National Registries. Am. J. Epidemiol. 2016;183:294&#x2013;301. doi: 10.1093/aje/kwv169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwv169</ArticleId><ArticleId IdType="pmc">PMC4753279</ArticleId><ArticleId IdType="pubmed">26825926</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitkanou S., Della Gatta P., Foletta V., Russell A. The Role of Exercise as a Non-pharmacological Therapeutic Approach for Amyotrophic Lateral Sclerosis: Beneficial or Detrimental? Front. Neurol. 2019;10:783. doi: 10.3389/fneur.2019.00783.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00783</ArticleId><ArticleId IdType="pmc">PMC6652799</ArticleId><ArticleId IdType="pubmed">31379732</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Violi F., Tzatzarakis M., Mandrioli J., Malagoli C., Hatch E.E., Fini N., Fasano A., Rakitskii V.N., Kalantzi O.I., et al. Pesticides, polychlorinated biphenyls and polycyclic aromatic hydrocarbons in cerebrospinal fluid of amyotrophic lateral sclerosis patients: A case-control study. Environ. Res. 2017;155:261&#x2013;267. doi: 10.1016/j.envres.2017.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2017.02.025</ArticleId><ArticleId IdType="pubmed">28242563</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavaleri F. Review of Amyotrophic Lateral Sclerosis, Parkinson&#x2019;s and Alzheimer&#x2019;s diseases helps further define pathology of the novel paradigm for Alzheimer&#x2019;s with heavy metals as primary disease cause. Med. Hypotheses. 2015;85:779&#x2013;790. doi: 10.1016/j.mehy.2015.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2015.10.009</ArticleId><ArticleId IdType="pubmed">26604027</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chio A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E. Incidence of amyotrophic lateral sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng E., Yu S., Dou J., Jin W., Cai X., Mao Y., Zhu D., Yang R. Association between alcohol consumption and amyotrophic lateral sclerosis: A meta-analysis of five observational studies. Neurol. Sci. 2016;37:1203&#x2013;1208. doi: 10.1007/s10072-016-2575-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-016-2575-0</ArticleId><ArticleId IdType="pubmed">27103621</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jong S.W., Huisman M.H., Sutedja N.A., van der Kooi A.J., de Visser M., Schelhaas H.J., Fischer K., Veldink J.H., van den Berg L.H. Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: A population-based study. Am. J. Epidemiol. 2012;176:233&#x2013;239. doi: 10.1093/aje/kws015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kws015</ArticleId><ArticleId IdType="pubmed">22791740</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman M.H., Seelen M., van Doormaal P.T., de Jong S.W., de Vries J.H., van der Kooi A.J., de Visser M., Schelhaas H.J., van den Berg L.H., Veldink J.H. Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis. JAMA Neurol. 2015;72:1155&#x2013;1162. doi: 10.1001/jamaneurol.2015.1584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.1584</ArticleId><ArticleId IdType="pubmed">26280944</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji J., Sundquist J., Sundquist K. Association of alcohol use disorders with amyotrophic lateral sclerosis: A Swedish national cohort study. Eur. J. Neurol. 2016;23:270&#x2013;275. doi: 10.1111/ene.12667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12667</ArticleId><ArticleId IdType="pubmed">25641323</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K., Kihira T., Kondo T., Kobashi G., Washio M., Sasaki S., Yokoyama T., Miyake Y., Sakamoto N., Inaba Y., et al. Lifestyle factors and risk of amyotrophic lateral sclerosis: A case-control study in Japan. Ann. Epidemiol. 2009;19:359&#x2013;364. doi: 10.1016/j.annepidem.2009.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2009.01.015</ArticleId><ArticleId IdType="pubmed">19342254</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson L.M., McGuire V., Longstreth W.T., Jr., Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am. J. Epidemiol. 2000;151:156&#x2013;163. doi: 10.1093/oxfordjournals.aje.a010183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a010183</ArticleId><ArticleId IdType="pubmed">10645818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F., Umbach D.M., Munsat T.L., Shefner J.M., Sandler D.P. Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology. 1999;18:194&#x2013;202. doi: 10.1159/000026211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000026211</ArticleId><ArticleId IdType="pubmed">10364720</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giorgio F., Maduro C., Fisher E.M.C., Acevedo-Arozena A. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis. Dis. Model. Mech. 2019;12 doi: 10.1242/dmm.037424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.037424</ArticleId><ArticleId IdType="pmc">PMC6361152</ArticleId><ArticleId IdType="pubmed">30626575</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wang Q., Wang Q., Liu H., Zhou F., Zhang Y., Yuan M., Zhao C., Guan Y., Wang X. DDX3 binding with CK1epsilon was closely related to motor neuron degeneration of ALS by affecting neurite outgrowth. Am. J. Transl. Res. 2017;9:4627&#x2013;4639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5666070</ArticleId><ArticleId IdType="pubmed">29118923</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao P.S., Sari Y. Glutamate transporter 1: Target for the treatment of alcohol dependence. Curr. Med. Chem. 2012;19:5148&#x2013;5156. doi: 10.2174/092986712803530511.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986712803530511</ArticleId><ArticleId IdType="pmc">PMC3486951</ArticleId><ArticleId IdType="pubmed">22680643</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>